TCPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TCPC is not a good buy right now for a beginner long-term investor with $50,000-$100,000 ready to deploy. The stock is trading in a clear downtrend, fundamentals and sentiment are weak, analysts are turning more negative, and recent news adds regulatory and valuation uncertainty. Even though the RSI is deeply oversold and insiders have been buying, the current setup is better suited to avoiding the stock than entering aggressively.
The technical picture is bearish. MACD histogram is -0.0734 and still expanding lower, showing downside momentum. RSI_6 at 16.024 is deeply oversold, which can support a short-term bounce, but oversold alone does not override the broader trend. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a sustained downtrend. Price at 3.695 is below the pivot at 4.016 and near the S1 support at 3.766, with next support at 3.611. The stock trend model also points lower over the next day, week, and month.
["Insiders are buying, with buying amount up 1284.25% over the last month.", "RSI is deeply oversold, which could allow for a technical rebound.", "Ares Management disclosed new investments including an initial investment in BlackRock TCP Capital."]
["The DOJ is investigating BlackRock TCP Capital's valuation practices.", "Federal prosecutors are examining BlackRock's private credit fund valuation practices, increasing uncertainty around asset impairments.", "Analysts say the company reported a very poor quarter and wrote down several investments.", "Net asset value was reduced by 19%, and Keefe Bruyette expects further pressure on book value.", "Price target was cut sharply to $3.50 from $7 and the stock was downgraded to Underperform.", "Hedge funds are neutral and there are no strong institutional accumulation signals.", "No recent congress trading data was found.", "The price trend model expects negative performance over the next day, week, and month."]
No full financial snapshot was available, but the latest quarter was described by analysts as very poor. The company reportedly wrote down several investments, which reduced net asset value by 19%. That points to deteriorating asset quality and weakening quarterly fundamentals. The missing financial snapshot prevents a deeper revenue or earnings growth review, but the available data clearly indicates weak recent quarterly performance.
The analyst trend is negative. On 2026-03-03, Keefe Bruyette downgraded TCPC to Underperform from Market Perform and cut the price target to $3.50 from $7 after calling the quarter very poor. The firm highlighted significant investment write-downs and a 19% NAV decline, and expects these issues to continue weighing on book value. Wall Street’s view is therefore bearish, with the main con being valuation pressure and asset impairment risk. The only notable pro is that the current price is near the revised target, but that is not a strong buy case.
